European Journal of Preventive Cardiology

Scope & Guideline

Elevating knowledge in cardiovascular disease prevention.

Introduction

Explore the comprehensive scope of European Journal of Preventive Cardiology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore European Journal of Preventive Cardiology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2047-4873
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1999 to 2000, from 2003 to 2024
AbbreviationEUR J PREV CARDIOL / Eur. J. Prev. Cardiol.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The European Journal of Preventive Cardiology focuses on advancing the understanding and practice of preventive cardiology through rigorous research. The journal aims to disseminate knowledge related to cardiovascular disease prevention, risk assessment, and management strategies.
  1. Cardiovascular Risk Assessment and Prediction:
    The journal emphasizes the development and validation of cardiovascular risk prediction models, addressing the challenges in predicting outcomes across diverse populations.
  2. Lifestyle and Behavioral Interventions:
    A significant focus is placed on lifestyle modifications, including exercise, dietary changes, and psychosocial factors, which are crucial for the prevention and management of cardiovascular diseases.
  3. Pharmacological Interventions:
    Research on the efficacy and safety of various pharmacological treatments, particularly lipid-lowering therapies and antihypertensives, is a central theme.
  4. Epidemiology and Public Health:
    The journal publishes studies that explore the epidemiology of cardiovascular diseases, highlighting trends, risk factors, and the impact of social determinants on cardiovascular health.
  5. Innovative Therapeutic Approaches:
    There is a keen interest in exploring novel therapeutic strategies, including the use of emerging drugs and technologies in the prevention and treatment of cardiovascular diseases.
  6. Interdisciplinary Approaches:
    The journal promotes interdisciplinary research involving cardiology, endocrinology, nephrology, and other fields to address the multifactorial nature of cardiovascular diseases.
The European Journal of Preventive Cardiology is witnessing a dynamic shift towards several emerging themes that reflect current trends in cardiovascular research and public health.
  1. Holistic and Multidisciplinary Approaches:
    Research is increasingly focusing on holistic strategies that incorporate physical, mental, and social health perspectives in cardiovascular prevention and rehabilitation.
  2. Digital Health and Telemedicine:
    There is a growing interest in the application of digital health technologies and telemedicine in cardiovascular care, especially in the context of the COVID-19 pandemic.
  3. Personalized Medicine:
    Emerging themes include the personalization of cardiovascular prevention strategies based on genetic, metabolic, and lifestyle factors, aiming to tailor interventions to individual patient needs.
  4. Environmental and Socioeconomic Impacts:
    Studies exploring the impact of environmental factors, such as air pollution and socioeconomic status, on cardiovascular health are gaining prominence.
  5. Women’s Cardiovascular Health:
    There is an increasing focus on women's cardiovascular health, addressing specific risk factors, outcomes, and preventive strategies tailored for women.
  6. Integration of AI and Machine Learning:
    Research exploring the use of artificial intelligence and machine learning in predicting cardiovascular risk and outcomes is emerging as a significant trend.

Declining or Waning

While the journal continues to publish a wide range of topics, certain areas of focus appear to be waning in prominence based on recent publication trends.
  1. Traditional Risk Factors:
    Research centered around traditional cardiovascular risk factors such as cholesterol levels and hypertension management is becoming less prevalent, as newer studies focus on integrated and holistic approaches.
  2. Single-Disease Studies:
    There is a noticeable decline in studies that examine cardiovascular diseases in isolation, with a shift towards understanding comorbidities and the interplay between multiple health conditions.
  3. Basic Science Research:
    The journal's focus on basic science research related to cardiovascular biology has decreased, as there is a greater emphasis on clinical and translational research that addresses real-world applications.
  4. Acute Cardiovascular Events:
    The emphasis on acute cardiovascular events, such as myocardial infarction, is diminishing, with more attention being directed towards preventive strategies and long-term management.

Similar Journals

CANADIAN JOURNAL OF CARDIOLOGY

Empowering Cardiovascular Innovations Through Rigorous Research
Publisher: ELSEVIER SCIENCE INCISSN: 0828-282XFrequency: 12 issues/year

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

CARDIOVASCULAR RESEARCH

Connecting research to real-world cardiovascular solutions.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

CURRENT CARDIOLOGY REVIEWS

Fostering Collaboration for Enhanced Patient Care
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

Clinica e Investigacion en Arteriosclerosis

Pioneering research that shapes the future of cardiology.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

International Heart Journal

Driving Progress in Cardiology and Patient Outcomes
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Acta Cardiologica Sinica

Fostering Innovation in Cardiovascular Medicine.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

Korean Circulation Journal

Exploring the Frontiers of Cardiac Research and Innovation.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Netherlands Heart Journal

Bridging Research and Practice in the World of Cardiovascular Medicine
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Current Vascular Pharmacology

Exploring the Frontiers of Cardiovascular Pharmacology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

Journal of the American Heart Association

Shaping the Future of Cardiovascular Medicine Together
Publisher: WILEYISSN: Frequency: 24 issues/year

The Journal of the American Heart Association, published by WILEY, serves as a premier platform for advancing cardiovascular medicine through its commitment to open access, fostering global dissemination of cutting-edge research since 2012. It proudly holds a prestigious position within the top quartile (Q1) in the categories of Cardiology and Cardiovascular Medicine, as evidenced by its Scopus ranking of #49 out of 387 journals, placing it in the 87th percentile. With a focus on innovative studies and transformative findings, this journal is essential for cardiologists, researchers, and healthcare professionals seeking to stay at the forefront of cardiovascular knowledge. The journal aims to bridge the gap between basic science and clinical practice, presenting findings that shape the future of heart health treatment and prevention. As a resource for academic and clinical communities alike, the Journal of the American Heart Association is dedicated to enhancing the understanding and treatment of cardiovascular diseases globally.